Literature DB >> 21742372

Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.

Akila Subramaniam1, Kenneth H Kim, Shannon A Bryant, Kristopher J Kimball, Warner K Huh, J Michael Straughn, Jacob M Estes, Ronald D Alvarez.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the incidence of mechanical complications associated with low-profile subcutaneous implantable venous access devices in gynecologic oncology patients.
METHODS: Gynecologic oncology patients with low-profile Port-a-Caths implanted between March 2005 and July 2006 were identified into a computerized database. Patient demographics, operative complications, number of chemotherapy cycles, duration of implantation, and mechanical complications were collected. Primary outcomes included port leakage, catheter fracture, and catheter embolization.
RESULTS: 112 patients underwent 115 Port-a-Cath placements with low profile single-lumen plastic ports with Groshong-valved catheters. Mean Port-a-Cath indwelling duration was 197 days (range: 4-395) with a mean number of 12 chemotherapy cycles (range 0-64). The cumulative complication rate necessitating removal or replacement was 15%. Of the 14 Port-a-Caths removed, ten (8.7%) were secondary to mechanical malfunction: one for leakage at the port site, two for catheter fracture, and seven for fracture with catheter embolization to the heart or pulmonary vasculature-most commonly the right ventricle. Patients with embolization were asymptomatic and all embolized catheters were successfully retrieved by interventional radiology without complications.
CONCLUSIONS: The rates of catheter fracture and embolization have previously been reported to be low in patients with subcutaneous Port-a-Caths, and have not been studied in patients receiving low-profile subcutaneous Port-a-Caths. This study suggests that catheter fracture may be more common (8.7%) and must be considered in patients with malfunctioning low-profile Port-a-Caths. Embolized catheters can be removed by interventional radiology without significant adverse affects.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742372     DOI: 10.1016/j.ygyno.2011.06.012

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Long-term outcomes of totally implantable venous access devices.

Authors:  Yi-Chia Wang; Pei-Lin Lin; Wei-Han Chou; Chih-Peng Lin; Chi-Hsiang Huang
Journal:  Support Care Cancer       Date:  2017-02-09       Impact factor: 3.603

2.  Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer.

Authors:  Fangmei Qi; Hairong Cheng; Xiying Yuan; Li Zhang
Journal:  Oncol Lett       Date:  2020-06-15       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.